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University of Pittsburgh, 2006
 
Asthma is a chronic inflammatory condition characterized by acute bronchoconstriction 
and a protracted inflammatory response marked by elevated levels of T-helper (Th)-2 cytokine 
production.  Common precipitants of asthma exacerbation include allergens (e.g. pollen), viruses 
(e.g. URI); however, recent evidence has demonstrated that psychological stress can also be a 
trigger. While the pathophysiological mechanism linking stress and asthma exacerbation is 
unknown, modulation of the immune system has been proposed as one potential pathway.  The 
primary aim of this study was to examine impact of examination stress (i.e. Pennsylvania bar 
exam) on Th2 and Th1 cytokine production and other asthma-relevant immune parameters 
among asthmatics and healthy controls.  To this end, five mild asthmatics and 10 healthy 
controls completed a battery of psychosocial measures and underwent venipuncture for 
immunological assessment one week prior and one month following the Pennsylvania bar exam.  
Overall, participants reported greater levels of distress during the exam period when compared to 
the post-exam period.  With respect to immunological changes, a group (asthmatic vs non-
asthmatic) by period (exam vs. post-exam) interaction was observed on Th1 cytokine production, 
with non-asthmatic participants showing a stress-related decrease in Th1 cytokine production, 
i.e. IFN-gamma production.  In addition, basal differences in IFN-gamma production were 
observed with asthmatics producing lower levels of IFN-gamma relative to non-asthmatics, 
potentially rendering asthmatics more susceptible to viral infections.  Exploratory analyses of 
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health behaviors revealed an intriguing relationship between alcohol consumption and IFN-
gamma production that warrants further investigation.  Future studies employing larger sample 
sizes are needed to better interpret these findings.   
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1.0  INTRODUCTION 
Asthma is a common chronic disease marked by intermittent episodes of airflow 
obstruction and hypersensitivity to normally benign proteins. During an episode, asthmatics 
experience acute bronchoconstriction, mucus hypersecretion, and a protracted inflammatory 
response (Busse & Lemanske, 2001). Currently, approximately 16 million people within the 
United States are affected by this disease, which has a lifetime prevalence of approximately 25 
million individuals, 12% of the U.S. population (CDC, 2002).  Despite a concerted effort by 
national health institutions to design more effective asthma treatments, the prevalence of asthma 
has consistently risen over the past two decades (CDC, 2002).   
Primarily considered a disorder of immune function, asthmatics display stable 
immunological differences when compared with non-asthmatics, including elevated T helper 
(Th) 2 cytokine production and increased numbers of eosinophils in both the bronchial mucosa 
and in peripheral circulation  (Busse & Lemanske, 2001).  Within asthmatics, higher Th2 
cytokine production has been positively associated with asthma severity and may confer 
increased risk for asthma exacerbation (Humbert et al., 1997; Sandford et al., 2000).  In addition, 
Th2 cytokines have the capacity to down regulate Th1 cytokine activity, which may render 
asthmatics more vulnerable to upper respiratory infection (URI), a known trigger of asthma 
episodes (Jung et al., 1995; Marshall & Agarwal, 2000).   
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Known precipitants of asthma exacerbation include allergens, cold air, exercise and, in 
some cases, psychological stress.  In regard to the latter, a large body of evidence links 
psychological stress and emotional arousal to increased subjective report of asthma symptoms as 
well as objective declines in pulmonary functioning (Lehrer, Feldman, Giardino, Song & 
Schmaling, 2002; Schmaling, Lehrer, Feldman & Giardino, 2003).  Furthermore, recent 
prospective evidence reveals that stressful life events precipitate asthma exacerbations 
(Sandberg, Jarvenpaa, Penttinen, Paton & McCann, 2004).   
One possible mediator of stress-related exacerbation of asthma is modulation of immune 
function, influencing host responses to allergens and susceptibility to viral infections that often 
precipitate asthma episodes.  In this regard, it is well established that psychological stress is 
associated with modulation of immune function (Herbert & Cohen, 1993; Marsland, Bachen, 
Cohen & Manuck, 2001), including an elevation in Th2 cytokine production (Segerstrom & 
Miller, 2004) that may increase risk of asthma exacerbation.  To date, however, this literature has 
focused on the stress-related immune responses of healthy individuals, with only a handful of 
studies examining these relationships among asthmatics.  Thus, the primary purpose of the 
current investigation was to explore this possible pathway by examining stress-related changes in 
Th2 and Th1 cytokine production, circulating numbers of eosinophils, and serum IgE levels 
among asthmatics and non-asthmatics.  For this purpose, a quasi-experimental study examining 
immune responses to examination stress was conducted.    
Before turning to a presentation of the study methods, a brief overview of the 
pathophysiology of asthma is offered to orient the reader. This is followed by an overview of 
existing evidence for associations between stress, immune function, and the exacerbation of 
asthma.   
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2.0  WHAT IS ASTHMA? 
Asthma, as defined by National Heart, Lung and Blood Institute (NHLBI, 1997), is a 
chronic inflammatory disorder of the airways characterized by episodes of widespread and 
variable airflow obstruction that are reversible spontaneously or with treatment.  In susceptible 
individuals, inflammation of the airways causes recurrent episodes of wheezing, breathlessness 
and chest tightness.  This can be accompanied by autonomic bronchial hyperresponsiveness to 
various external stimuli, further contributing to reduced airflow.  Asthma symptoms tend to 
worsen during the night and in the early morning.  Treatment involves a prophylactic medication 
regimen that can include short and long acting beta-agonists, inhaled corticosteroids and 
leukotriene antagonists.    
Typically, the onset of asthma is in childhood, with a variable course resolving for many 
prior to adolescence, but continuing for others throughout adulthood  (Sears et al., 2003).  The 
majority of individuals predisposed to asthma have an atopic phenotype, which is the tendency to 
respond to normally benign proteins with inflammatory processes characterized by elevated Th2 
cell activity and the production of immunoglobin E (IgE) (Novak & Bieber, 2003).  IgE is the 
antibody responsible for classic allergic reaction.  While the specific factors that promote the 
development of an atopic phenotype are unclear, genetic and environmental factors (e.g. early 
exposure to allergens and viruses) are thought to play a role (Busse & Lemanske, 2001).   
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2.1 THE IMMUNOLOGY OF ASTHMA 
The elevated Th2 activity that is characteristic of asthma results in greater production of 
the Th-2 cytokines,  interleukin (IL)-4 and 5 (Bettiol et al., 2000; Rodriguez et al., 1998; Shiota 
et al., 2002).  These cytokines initiate allergic inflammation, contribute to asthma exacerbations 
(Busse & Lemanske, 2001), and are related to greater asthma severity (Humbert et al., 1997).  
Th1 and Th2 cytokines are mutually inhibitory (Jung et al., 1995; Maggi et al., 1992), which 
explains findings that asthmatics also produce lower levels of Th1 cytokines following 
stimulation by a nonspecific mitogen than non-asthmatics (Rodriguez et al., 1998).  Th1 cells 
secrete cytokines, including interferon (IFN)-gamma and IL-2, that are involved in  cellular 
immune responses to invading intracellular pathogens (e.g. viruses)(Liu, 2000).  Thus, it is 
proposed that patterns of Th1:Th2 activation that accompany asthma promote a down-regulation 
of cellular immune function and an up-regulation of inflammatory pathways (Marshall & 
Agarwal, 2000), rendering the individual more susceptible to  asthma exacerbation via a decrease 
in host resistance to viral infection and/or an increase in allergic response.   
Asthma is an inflammatory disorder of complex and integrated immune processes.  In 
addition to T-helper cells and their cytokines, immune components known to play a major role 
include B cells, eosinophils, mast cells, and chemical mediators, such as chemokines, which are 
known to be instrumental in promoting bronchial autonomic hyperresponsiveness, mucus 
hypersecretion and the influx of immune cells into the bronchial mucosa.  Accumulation of  
immune cells, particularly eosinophils, in the bronchial tract, and related inflammation contribute 
to the impediment of airflow that is a cardinal symptom of an asthma episode (Krishna, Salvi & 
Holgate, 2001).  Even between acute asthma episodes, asthmatics have higher numbers of 
eosinophils in peripheral circulation than non asthmatics (Lewis et al., 2001; Ulrik, 1998).   
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Studies examining the immunopathology of allergen-induced asthma exacerbation 
demonstrate a clear 2 phase process (Krishna et al., 2001), with an early phase that starts within 
15 minutes of  exposure to the allergen, followed by a late phase occurring 2-6 hours later.  
During the early phase, allergen proteins are taken up by dendritic cells and macrophages that 
line the airway. These antigen-presenting cells (APCs) travel to  lymph nodes where they present 
the processed antigen to  T and B cells, stimulating the activation of Th2 cells and the release of 
IL-4 and IL-5.  These cytokines activate the humoral immune system, resulting in isotype 
switching of B cells to produce IgE.  Once released from B cells, IgE cross-links with mast cells, 
resulting in the release of preformed mediators such as histamine and leukotrienes that cause 
constriction of the bronchial smooth muscle, and the onset of asthma symptoms (Krishna, Salvi 
& Holgate, 2001).     
The late phase of an asthma exacerbation is marked by excessive inflammation as well as 
narrowing of the bronchial tract secondary to smooth muscle constriction.   During this phase, 
elevated levels of IL-5 secreted by Th2 cells into the circulatory system promote the 
differentiation and migration of eosinophils from the bone marrow to the airway (Shi et al., 
1998) contributing to airflow obstruction.  Peripheral blood levels of both eosinophils and IL-5 
have been shown to correlate highly with levels in the bronchial mucosa (Liu et al., 2002).  
Furthermore, in a recent study, mild asthmatics treated with monoclonal antibodies to IL-5 
displayed reduced levels of blood and sputum eosinophils following an inhaled allergen 
challenge (Leckie et al., 2000).   
Triggers of asthma episodes vary widely across individuals and include allergens (e.g. 
pollen, cockroaches, pet dander), smoking, cold air, exercise and URI.  In addition, evidence 
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suggests that psychological stress and/or emotional arousal may play a role (Lehrer, Isenberg & 
Hochron, 1993; Schmaling et al., 2003).  This is the primary focus of the current study.                  
2.2 INFLUENCE OF STRESS ON ASTHMA EXACERBATION 
There is no one single, widely accepted definition of stress. For the purposes of this study 
stress is conceptualized as a psychological process that elicits an adaptive physiological 
response.  Often associated with a negative emotional state, an individual experiences stress 
when he or she determines that the environmental demands exceed their ability to access coping 
resources (Lazarus & Folkman, 1984).  The ability to access adaptive coping resources in the 
presence of a stressor is thought to be a product of past experience, personality and presence or 
absence of social resources (e.g. social support) (Cohen, Doyle, Skoner, Rabin & Gwaltney, 
1997; Cohen & Herbert, 1996).   
A controversial issue in asthma research concerns the extent to which psychological 
stress contributes to asthma exacerbations.  Many asthmatics report that stress and emotional 
arousal play a significant role in precipitating their asthma attacks (Rees, 1980).  Moreover, 
documented case studies have shown increased susceptibility to asthma episodes following 
stressful life events (Levitan, 1985).  However, it is only recently that prospective studies have 
provided empirical support for this popular notion.   
Early studies were largely cross-sectional and while not all findings are consistent, they 
generally support a positive relationship between psychological stress and the exacerbation of 
asthma.  Indeed, in a review of this literature, Lehrer and colleagues (1993) concluded that 
negative emotion, thought to be elicited by stressful experience, was correlated consistently with 
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a higher frequency of subjective asthma symptoms (e.g. feelings of breathlessness) and often 
with a decline in pulmonary function. More recent cross-sectional studies provide further 
evidence for an association between stress and asthma.  Numerous stressors including family 
conflict, financial burden and the presence of depressive symptoms have been associated with 
more frequent asthma exacerbations (Sturdy et al., 2002), increased hospitalization (Chen, 
Bloomberg, Fisher & Strunk, 2003), and increased asthma mortality (Strunk, Mrazek, Fuhrmann 
& LeBrecque, 1985). Naturalistic field studies have found proximal relationships between daily 
stress and negative emotional states and poorer lung functioning among asthmatics (Apter et al., 
1997; Ritz & Steptoe, 2000; Steptoe & Holmes, 1985). In these studies, daily diaries are used to 
determine levels of perceived stress, current mood and the occurrence of stressful life events.  
Each diary entry generally corresponds with an objective measure of lung function (e.g. peak 
expiratory flow rate (PEFR) or forced expiratory volume in one second (FEV1). For example, 
Ritz and Steptoe (2000) followed 20 asthmatics and 20 non-asthmatics over 21 days and found 
that an average decrease in lung function of 7.9% accompanied negative emotions relative to 
neutral experiences among only the asthmatics; in fact, five asthmatics showed decreases in 
FEV1 of greater than 15%.  
In sum, a large literature supports a positive relationship between stress and asthma; 
however, the cross-sectional nature of the studies makes it impossible to determine the direction 
of these effects. Indeed, asthma is characterized by unpredictable and uncontrollable 
exacerbations, making it likely that more severe disease results in heightened stress and negative 
emotional reactions and influences retrospective recall of precipitating events.  To better 
examine causal relationships, experimental studies have been conducted. In these studies, 
asthmatics are presented with an acute emotional stimulus and their pulmonary functioning is 
 7 
measured in response to a bronchoconstricting chemical or saline challenge.  In a review of this 
literature, Isenberg, Lehrer, and Hochron (1992) reported that approximately 20% of asthmatics 
responded with a significant decline in pulmonary functioning in response to emotional arousal.  
However, small samples sizes, difficulties with replication, and a lack of standard demographic 
and background controls (e.g. measures of asthma severity, medication usage) make it difficult to 
draw firm conclusions about the role of stress and emotional arousal in precipitating asthma 
exacerbation (Isenberg et al., 1992).  
More recently a prospective study has provided further support for the role of stress as a 
trigger of asthma exacerbation.  In this study, Sandberg and colleagues (2004) examined whether 
negative stressful life events precipitated asthma exacerbations among asthmatic children.  For 
this purpose, 60 children with chronic asthma were followed for 18 months and completed daily 
diaries monitoring asthma symptoms and negative life events. Acute exacerbations were defined 
as a documented fall in PEFR below 70% of the child’s normal value combined with an increase 
in reported symptoms.  Children who reported the presence of a severely negative life event (e.g. 
moving, traumatic events, family problems) were significantly more likely (OR= 4.69) to have 
an asthma attack within the next 2 days.  This finding provides persuasive initial evidence that 
stress may play a clinically relevant role in promoting asthma exacerbations.  
In conclusion, it is well established that psychological stress is associated with increased 
subjective report of asthma symptoms as well as objective declines in pulmonary functioning, 
with recent prospective evidence showing that stressful life events precipitate asthma 
exacerbations in children (Sandberg et al., 2004). These empirical findings support anecdotal 
evidence from asthma sufferers who report that stress increases their susceptibility to 
exacerbation. Although evidence is mounting that stress can exacerbate asthma, at least for a 
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subgroup of asthmatics, the mechanism of this effect remains to be determined (Wright, 
Rodriguez and Cohen, 1998).  The purpose of this investigation was to begin to examine a 
potential pathway of this relationship by examining whether life event stress was associated with 
inflammatory mechanisms known to play a role in the pathophysiology of asthma.  
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3.0  PATHWAYS LINKING STRESS AND IMMUNE FUNCTION 
Stress sets in motion a cascade of biological processes including activation of the 
hypothalamic-pituitary adrenal (HPA) axis and the autonomic nervous system (ANS).  In 
addition, stress is associated with changes in health behaviors.  In the following sections, the 
possibility that stress-related changes in these biological and behavioral processes act as potential 
pathways by which stress influences immune parameters relevant to asthma is considered.  
Asthma 
Exacerbation 
Allergen Virus
↑ susceptibility to 
airway inflammation 
↑ susceptibility to URI 
Immune dysregulation 
Autonomic dysregulation HPA axis dysregulation Health behaviors 
Negative Emotional 
Response 
Psychological Stress 
Figure 1: Proposed model linking stress and asthma exacerbation 
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 3.1 NEUROENDOCRINE AND AUTONOMIC PATHWAYS 
Stress-induced activation of the HPA axis and the ANS leads to the systemic release of a 
number of neurochemicals, including corticosteroids and catecholamines, which can bind to 
receptors on immune cells that migrate between lymphoid organs and the peripheral blood 
stream.  It is known that these neurochemicals have the capacity to modulate immune function, 
including immune parameters relevant to asthma pathophysiology (Rabin, 1999). With respect to 
the HPA axis, it is widely accepted that elevated levels of the corticosteroids accompany 
psychological stress (Dickerson & Kemeny, 2004; Wolkowitz, Epel & Reus, 2001).  In general, 
cortisol has anti-inflammatory properties. Indeed, corticosteroids are widely prescribed in the 
treatment of asthma-related inflammation. Paradoxically, however, a number of pathways have 
been proposed that also link cortisol to the promotion of asthma-related inflammatory processes 
(Wright, Cohen & Cohen, 2005) 
Cortisol plays an important role in the modulation of the production and release of 
cytokines. In general, cortisol acts to “shut off” the release of proinflammatory cytokines. 
However, in vitro studies show that cortisol can also stimulate the production of the Th2 
cytokines, IL-4 and IL-5 (Agarwal & Marshall, 1998; Chrousos, 1995), possibly increasing 
allergic response. Moreover, cortisol can downregulate Th1 cytokine production (e.g. IFN-
gamma) potentially increasing URI susceptibility (Agarwal & Marshall, 2001).  Other studies 
suggest that prolonged elevation of cortisol levels, possibly as a result of chronic stress or 
corticosteroid treatment, can result in adaptation of the HPA axis and the development of 
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glucocorticoid resistance (Miller, Cohen, and Ritchey, 2002). In this case, the glucocorticoid 
receptors become less sensitive to cortisol, allowing the production of pro-inflammatory 
cytokines to go unchecked.  Indeed, approximately 5% of asthmatics develop glucocorticoid 
resistance in response to corticosteroid treatment (Leung, 1995). 
Stress is also associated with activation of the sympathetic branch of the ANS and the 
associated release of catecholamines into peripheral circulation.  Catecholamines, such as 
epinephrine and norepinephrine, released during times of stress have the capacity to modulate 
immune function.  For instance, in vitro and in vivo studies have demonstrated that epinephrine 
and norepinephrine can act on peripheral blood cells to produce elevated levels of Th2 cytokines 
(Agarwal & Marshall, 2000) as well as increase the circulating numbers of T cells (Bachen et al., 
1995).  
Another pathway by which stress-induced ANS activation may influence asthma 
exacerbation is through direct innervation of the smooth muscle of the airways.  Although direct 
sympathetic innervation of the bronchus is sparse, the parasympathetic arm of the ANS 
innervates airway smooth muscle via efferent fibers of the vagus nerve and directly influences 
contraction of the airways through cholinergic activation.  It has been suggested that vagal nerve 
activity may contribute to bronchoconstriction, bronchial reactivity and mucus hypersecretion 
(Jartti, 2001). To date, studies examining whether stress results in exacerbation of asthma via 
autonomic regulation of airways are inconclusive (Isenberg et al., 1992; Lehrer et al., 1996; 
Lehrer et al., 1993). However, eosinophils have been shown to interact with cholinergic nerves to 
promote increased release of acetylcholine in the airway (Sawatzky, Kingham, Durcan, McLean 
& Costello, 2003), providing a potential immunologic pathway to bronchoconstriction. 
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Taken together, findings suggest that stress-induced activation of the HPA axis and ANS 
may promote asthma exacerbation via modulation of immune function salient to asthma 
pathophysiology. While a large literature supports the role of neurochemicals, such as 
catecholamines and cortisol, in modulating immune function, limited research has examined 
these changes in the context of asthma. 
3.2 BEHAVIORAL PATHWAYS 
In addition to direct activation of biological pathways stress may influence immunity via 
the indirect influence of health behaviors.  For example, poor nutritional status, smoking, lack of 
physical activity, alcohol use, poor sleep quality and poor social connectedness are more likely at 
times of high stress and have been related to modulation of immune function (e.g., Kiecolt-
Glaser & Glaser, 1988). In the current study, the potential roles of alcohol consumption, physical 
activity and sleep are considered. Alcohol consumption is often used as a method of coping with 
elevated levels of stress (Johnson & Pandina, 2000).  Although alcohol use is not commonly 
considered a trigger of asthma exacerbation, recent evidence suggests that moderate alcohol 
consumption may influence inflammatory processes of relevance to asthma.  For instance, 
moderate alcohol consumption has been associated with a down-regulation of host resistance to 
viral and bacterial infection (Szabo, 1999); however, not all findings are consistent and other 
studies suggest that alcohol use may increase resistance to URI (Cohen et al., 1997; Cohen, 
Tyrrell, Russell, Jarvis & Smith, 1993).  Alcohol use has also been associated with increased 
activation of Th2-related immune pathways, including the promotion of IgE hypersensitivity to 
various allergens (Gonzalez-Quintela, Vidal & Gude, 2004), as well as a shift towards IL-4 
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production (Szabo, 1999). Thus, it is possible that alcohol consumption at times of stress could 
impact immune processes that are involved in inflammatory diseases, such as asthma.    
Sleep is another health behavior that is subject to change at times of stress.  Decrements 
in sleep quality and quantity have been associated with elevated levels of inflammation and pro-
inflammatory cytokine production (Motivala, Sarfatti, Olmos & Irwin, 2005; Pollmacher et al., 
2000).  Moreover, poor sleep efficiency has also been associated with decreased host resistance 
to URI (Cohen et al., 1997).  Interestingly, recent evidence suggests that there is  a diurnal 
pattern of cytokine release across a typical night’s sleep, with a shift towards Th2 cytokine 
production during late night sleep (Dimitrov, Lange, Tieken, Fehm & Born, 2004), a time when 
asthma symptoms are more prevalent. It is possible that stress-related changes in sleep may 
disrupt this pattern and modulate risk of asthma exacerbation.   
A final health practice of interest in the current study is physical activity.   Higher levels 
of perceived stress and negative affect have been associated with decreased energy and physical 
activity (Allgower, Wardle & Steptoe, 2001; Baum & Posluszny, 1999).  As lack of physical 
activity has also been associated with higher levels of pro-inflammatory cytokines (Nicklas, You 
& Pahor, 2005), this provides another potential pathway linking stress to the exacerbation of 
inflammatory disease.   
In sum, there is extensive evidence for direct anatomical and functional links as well as 
indirect behavioral links between the central nervous and immune system, providing potential 
pathways for the influence of stress on immune function.  In turn, this raises the possibility that 
stress-related changes in immune function link stress to asthma exacerbation.   
 14 
3.3 UPPER RESPIRATORY INFECTION AND ASTHMA 
Another pathway by which stress could exacerbate asthma is via its association with 
increased susceptibility to URI.  Experimental viral challenge studies, inoculating healthy 
individuals with common cold virus or placebo, have clearly shown that stressful life events 
predict the probability of developing a biologically-verified cold, with greater stress related 
linearly to increased susceptibility (Cohen, Tyrrell & Smith, 1991; Cohen et al., 1998).  To date, 
however, the biological mechanisms of stress-related susceptibility to viral infection remain 
unknown.  It has been speculated that the production of  cytokines may play a significant role 
(Cohen & Rodriguez, 2000).   In this regard, stress is associated with the decreased production of 
Th1 cytokines that are involved in mounting a cellular immune response to viral challenge and 
this may increase susceptibility to URI.  
The capacity for URI to promote asthma exacerbation is well documented. As many as 
50% of asthma exacerbations experienced among adults are precipitated by respiratory infections 
(Busse, 1990; Busse & Gern, 1997; Nicholson, Kent & Ireland, 1993). Furthermore, viral 
respiratory infections have been shown to promote allergic inflammation and increase airway 
autonomic reactivity (Folkerts, Busse, Nijkamp, Sorkness & Gern, 1998). For example, 
Lemanske and colleagues (1989) showed that inoculation with a common cold rhinovirus 
resulted in heightened bronchoconstriction to inhaled allergens among allergic rhinitis patients.  
Furthermore, these individuals continued to show increased frequency of late allergic reactions 
for as long as 4 weeks following inoculation.   
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4.0  STRESS, IMMUNE FUNCTION AND ASTHMA 
Several review articles (Glaser & Kiecolt-Glaser, 2005; Marsland et al., 2001) and meta-
analyses (Herbert & Cohen, 1993; Segerstrom & Miller, 2004) of the literature on stress and 
immunity in humans conclude that naturalistic stress (as measured by both self-report and 
chronic or brief life events) is reliably associated with modulation of functional and enumerative 
immune measures.  Examples of naturally occurring stressors associated with 
immunomodulation include loss of a loved one (Kemeny et al., 1995), marital conflict (Robles & 
Kiecolt-Glaser, 2003), caring for a relative with Alzheimer’s disease (Kiecolt-Glaser, Glaser, 
Gravenstein, Malarkey & Sheridan, 1996), and living near a damaged nuclear power plant 
(McKinnon, Weisse, Reynolds, Bowles & Baum, 1989). These stressors are consistently 
associated with functional alterations in immunity, including lower natural killer (NK) cell 
function, decreased T cell proliferation, and increased antibody production to latent viruses when 
compared with levels among non-stressed control groups.  In terms of enumerative parameters, 
stress is associated with reliable decreases in circulating numbers of B cells, T helper cells, T 
cytotoxic cells and NK cells.  Additionally, there is evidence that immune changes may persist 
with protracted stressor exposure (Baum, 1990). 
Further evidence for an association between stress and immune function comes from 
studies that employ a quasi-experimental design, examining immune function within individuals 
at times of high and low naturalistic stress. Probably best known in this literature are the series of 
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studies by Kiecolt-Glaser, Glaser and colleagues (Glaser et al., 1987; Glaser, Pearl, Kiecolt-
Glaser & Malarkey, 1994; Glaser et al., 1991; Glaser, Rice, Speicher, Stout & Kiecolt-Glaser, 
1986; Kiecolt-Glaser et al., 1986) examining immune responses of medical students to 
examination stress.  Of particular relevance to asthma, examination stress has been associated 
with  reliable elevations in the production of the Th2 cytokines, IL-6 and IL-10 and concomitant 
decreases in the Th1 cytokines,  IFN-gamma and IL-2, among healthy participants (Kang & Fox, 
2001; Marshall & Agarwal, 2000; Marshall et al., 1998; Paik, Toh, Lee, Kim & Lee, 2000).  For 
instance, Marshall and colleagues (1998) assessed immune function among 16 healthy first- year 
medical students 4 weeks prior to and 48 hours following medical school exams.  During the 
exam period, medical students showed relative increases in Th2 cytokine production as well as a 
decrease in the Th1:Th2 ratio when compared to cytokine production 4 weeks earlier.  In 
addition, number of daily hassles during the pre-exam period was inversely associated with 
Th1:Th2 cytokine production pre- and post-exam.    
To date, only a limited number of studies have examined the association between stress 
and immune function among an asthmatic population.  Overall, studies provide initial support for 
an increase in Th2 cytokine production among chronically stressed asthmatics.  For example, 
Chen, Fisher, Bacharier, and Strunk (2003) found that among asthmatics lower socioeconomic 
status (SES) was associated with a significantly higher level of IL-5 production when compared 
with higher SES.  Regression analysis showed that when stress and control beliefs were 
controlled SES no longer predicted IL-5 production suggesting that psychological stress may be 
driving this relationship. Similarly, studies examining immune responses to examinations show a 
stress-related increase in the production of Th-2 cytokine production among asthmatics. For 
example, Kang and colleagues ( 1997) examined cytokine production among 21 adolescent 
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asthmatics  and 13 healthy controls a month prior to final exams, during final exams and 2-3 
weeks following the exam period.  Although there were no significant changes in cytokine 
production across the three time periods, asthmatics produced significantly more mitogen 
stimulated IL-5 during the exam period and lower IL-2/IL-5 (Th1:Th2) ratios across all 3 periods 
than healthy controls..  The same finding was reported for IFN-gamma/IL-5 (Th1:Th2) during 
the exam and post-exam periods providing initial support for differential cytokine production at   
times of stress among asthmatics and healthy controls. Unfortunately, this study is limited by a 
failure to assess levels of perceived stress and thus to validate the examination stress paradigm.  
In a more recent study, the same group of investigators examined 24 college students (13 
with asthma and 11 without asthma) during the middle of the semester and again during the final 
exam week (Kang & Fox, 2001).  In contrast to their previous study, Kang and colleagues 
reported a significant exam-related increase in stress using a single item measure of stress, but 
not when assessed with the Perceived Stress Scale (PSS; Cohen, Kamarck & Mermelstein, 
1983). In this study, both groups displayed a significant increase in Th2 cytokine (IL-6) 
production as well as a decrease in Th1 cytokine (IFN-gamma and IL-2) production from before 
to during the exam period.  However, there were no stress-related changes in the production of 
IL-4 or IL-5 among asthmatics or controls. Asthmatics did show higher basal IL-5 production 
than controls. It is possible that their failure to find more significant effects is the consequence of 
the level of stress, with no detectable differences between exam and mid-semester periods on the 
PSS, a widely used and reliable measure of stress.  In addition, the asthmatics in this sample 
were heterogeneous with respect to asthma medication usage.  As a consequence, the 
immunomodulatory effects of asthma medication may have obscured further differences in 
cytokine production among asthmatic participants.   
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In contrast to studies that examine the impact of psychological stress on cytokine 
production within peripheral blood, Liu and colleagues (2002) utilized a more proximal model 
assessing changes in cytokine levels in sputum in response to the inhalation of  a nonspecific 
mitogen.  In this study, 20 mild asthmatic college students underwent the inhaled antigen 
challenge during a low stress period and again during final exams.  In addition to the cytokine 
assessment, percentages of eosinophils were evaluated both in sputum and in peripheral blood.  
Liu and colleagues reported a significant stress-related increase in IL-5 production in sputum 
following the inhaled antigen challenge.  Additionally, the percentage of eosinophils, assessed 
both in sputum and peripheral blood, were significantly elevated during the high versus low 
stress period with the percentage in sputum at 24 hours inversely associated with pulmonary 
function, as assessed by FEV1.   
Taken together, studies examining the impact of examinations on cytokine production 
among asthmatics and healthy individuals provide initial evidence for a stress-induced shift from 
Th1 to Th2 cytokine production.  This shift may have clinical implications for asthmatic 
individuals by (1) increasing their risk of airway inflammation in response to benign antigens, 
and (2) increasing their susceptibility to URI a known trigger of asthma episodes.  Unfortunately 
methodological shortfalls in the existing literature, including inconsistent measurement of 
psychological stress and variability in asthma medication usage, make it difficult to conclude that 
psychological stress is reliably associated with greater Th2 activity among asthmatics.  
Additionally, in light of the limited number of studies examining the impact of stress among 
asthmatics and available evidence linking stress to changes in cytokine production patterns that 
may confer increased susceptibility to asthma, further research examining the impact of 
psychological stress on cytokine production among asthmatics is warranted.  
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To this end, the primary aim of this study was to examine changes in Th1 and Th2 
cytokine production during periods of high and low stress among an asthmatic population and to 
determine whether these changes in cytokine production differ from those observed in healthy 
controls.  For this purpose, a quasi-experimental study was conducted examining immune 
responses to the stress of taking the Pennsylvania bar exam among asthmatics and healthy 
controls.   
4.1 HYPOTHESES 
Hypothesis 1:  Asthmatic and healthy participants will report higher levels of perceived 
stress, anxiety and negative affect prior to the bar exam relative to a lower stress period (1 month 
following the exam).   
Hypothesis 2:  Asthmatics will show higher basal levels of IL-4 and IL-5 and greater 
stress-related increases in stimulated levels of IL-5 and IL-4 production and concomitant 
decreases in IFN-gamma production when compared to healthy controls   
Hypothesis 3:  Asthmatics will show higher basal numbers of eosinophils and levels of 
IgE in peripheral circulation than non-asthmatics.  Asthmatics will also show greater stress-
related increases in circulating numbers of eosinophils than controls.  In addition, IL-5 
production will be associated with the levels of circulating eosinophils in peripheral blood during 
both high and low stress period.  
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5.0  METHODS 
The primary goal of this study was to examine the impact of examination stress on Th1 
and Th2 cytokine production in response to whole blood stimulation by phytohemagglutinin 
(PHA), a nonspecific mitogen, among mild asthmatics and healthy controls.  To this end, we 
employed a quasi-experimental design in which participants were assessed approximately 1 
week prior to taking the Pennsylvania bar exam (high stress period) and 1 month following the 
exam (low stress period).  This design allowed for the examination of differences in cytokine 
production both within and between asthmatic and non-asthmatic participants.     
5.1 PARTICIPANTS 
Sixteen recently graduated law students who were scheduled to take the Pennsylvania bar 
exam in July 2005 were recruited to take part in this study.  Individuals were eligible to 
participate if they were 1)  healthy or had been diagnosed with mild asthma by a physician 
sometime in their lifetime, 2)  non-smokers, 3)  free from systemic disorders or medications 
affecting the immune, nervous or endocrine systems, with the exception of asthma and asthma 
medications 4)  not currently being treated for a psychiatric disorder 5) consumed less than 15 
alcoholic beverages per week, and 6)  not experiencing an acute respiratory infection on days of 
data collection.  The study protocol was approved by the Institutional Review Board at the 
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University of Pittsburgh and informed consent was obtained from each student prior to 
participation. 
5.2 PROCEDURES 
The study consisted of two separate data collection periods.  The first study session took 
place at the Behavioral Immunology Laboratory, within one week of the Pennsylvania bar exam; 
participants returned for a second visit approximately 1 month later.  Laboratory sessions were 
generally scheduled in the morning, and great effort was made to ensure that time of day was 
kept consistent within subject.  Upon arrival, the study procedures were reviewed, any questions 
were answered and consent to participate was obtained.  Prior to any data collection, participants 
were screened for the presence of acute upper respiratory infections using modified Jackson 
criteria.  No participant met this criterion at either the exam or post-exam data collection period.  
Height and weight were obtained using a standard medical-grade balance scale.  Participants then 
completed a battery of psychological questionnaires and underwent a venipuncture to collect 12 
mls of blood for later assessment of immune functioning.  Participants were compensated $50 for 
taking part in both study sessions.  
5.3 PSYCHOLOGICAL MEASURES 
The following psychological questionnaires were completed at both study visits. The 
Perceived Stress Scale (PSS-10; Cohen, et al. 1983) was used to assess the degree to which 
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participants’ perceived their daily lives as unpredictable, uncontrollable, and overloading.  The 
PSS is a reliable measure of perceived stress (Cronbach’s coefficient alpha = .85; Cohen & 
Williamson, 1988).  Moreover, the PSS has been shown to be a reliable measure of the stress 
associated with taking professional examinations (Malarkey, Pearl, Demers, Kiecolt-Glaser & 
Glaser, 1995).  It was expected that this measure would confirm that high levels of stress were 
associated with preparing for the Pennsylvania bar exam.  
Negative affect was measured using Positive and Negative Affect Schedule- expanded 
form (PANAS-X; Watson & Clark, 1994).  The PANAS-X is considered to be a reliable measure 
of general positive and negative affect (Cronbach’s coefficient alpha for positive affect= .88, 
negative affect= .85; Watson & Clark, 1994).  Negative affect is often experienced during 
periods of stress.  Thus, it was expected that higher scores on the negative affect subscale of this 
measure would be observed prior to the examination when compared with a lower stress period.   
Anxiety was measured using the Speilberger State Anxiety Inventory (STAI; Spielberger, 
Gorsuch, Lushene, Vagg, and Jacobs, 1983).  The STAI is considered a reliable measure of state 
anxiety (Cronbach’s coefficient alpha= .92, Spielberger et al., 1983).  Anxiety is often 
experienced during periods of stress and thus was expected to increase during the examination 
period.   
The Beck Depression Inventory-2 (BDI-2; Beck, Steer, & Brown, 1996) was used to 
measure depression at both time points.  Research has found the BDI-2 to be a valid measure of 
depressive symptomatology (Cronbach alphas for the BDI  =  .92; Beck et al., 1996). This 
measure was employed to rule out individuals who met criteria for clinical depression (scores > 
19).   
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5.4 HEALTH BEHAVIORS 
A number of health behaviors known to be associated with both stress and immune 
parameters relevant to asthma exacerbation were measured, including sleep quality, physical 
activity and alcohol consumption.  Sleep quality was assessed using the Pittsburgh Sleep Quality 
Index (PSQI; Buysse, Reynolds, Monk, Berman & Kupfer, 1989). The PSQI is a well accepted 
and reliable measure of sleep quantity and quality over the past month.  (Cronbach coefficient 
alpha= .83; Buysse et al., 1989).  Physical activity was measured using the Paffenbarger Activity 
Index (PAI; Paffenbarger, Blair, Lee & Hyde, 1993).The PAI is a well accepted and reliable 
measure of the  average amount of physical activity per week (Cronbach coefficient alpha= .66-
.83; Paffenbarger et al., 1993). Finally, at both time points, participants were asked to report their 
average consumption of alcohol (number of alcoholic drinks/day), for both weekdays and 
weekends.      
5.5 BIOLOGICAL MEASURES 
A number of health behaviors known to be associated with both stress and immune 
parameters relevant to asthma exacerbation were measured, including sleep quality, physical 
activity and alcohol consumption.  Sleep quality was assessed using the Pittsburgh Sleep Quality 
Index (PSQI; Buysse, Reynolds, Monk, Berman & Kupfer, 1989). The PSQI is a well accepted 
and reliable measure of sleep quantity and quality over the past month.  (Cronbach coefficient 
alpha= .83; Buysse et al., 1989).  Physical activity was measured using the Paffenbarger Activity 
Index (PAI; Paffenbarger, Blair, Lee & Hyde, 1993).The PAI is a well accepted and reliable 
 24 
measure of the  average amount of physical activity per week (Cronbach coefficient alpha= .66-
.83; Paffenbarger et al., 1993). Finally, at both time points, participants were asked to report their 
average consumption of alcohol (number of alcoholic drinks/day), for both weekdays and 
weekends.      
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6.0  DATA ANALYSIS AND RESULTS 
Data was analyzed with SPSS version 14.0.  Initially, the distributions, descriptive 
statistics, and intercorrelations of all variables were examined to determine normality and 
multicollinearity. To correct for non-normally distributed data, natural log transformations were 
employed.  Pearson product-moment and point-biserial correlations were used to examine 
associations between demographic, psychosocial measures, self-report health behaviors and 
immune outcomes.  Based on these preliminary analyses, demographic and background variables 
found to be significantly associated with primary outcomes were treated as covariates in further 
analyses.   
Repeated measures analysis of variance (ANOVA) was employed to analyze the 
significance of overall group differences, cell responses across the two time points (exam and 
post-exam), and group x time interactions.  When appropriate, between and within group 
differences were examined using independent and paired t-tests.   
Finally, exploratory analyses were conducted to assess whether health behaviors were 
associated with both stress and cytokine production and thus could be a possible mediator of the 
effect of stress on cytokine production.  This study did not have the statistical power to test 
mediating effects. Thus relationships were examined using Pearson product-moment 
correlations.  Health behaviors found to correlate with immune outcomes were then treated as 
covariates.  
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6.1 PARTICIPANT STATISTICS 
Sixteen participants were recruited to take part in this study, 5 asthmatics and 11 non-
asthmatics.  One healthy participant was unable to be contacted for the post-exam period; 
therefore, the final sample consisted of 5 asthmatic and 10 non-asthmatic participants.  
Demographic information describing the sample is provided in Table 1.  All participants recently 
graduated from law school and were taking the Pennsylvania bar exam for the first time in July 
of 2005.  Participants ranged in age from 24-35 with a mean of 27.3 (SD= 3.17), they were 
primarily Caucasian (87%) and a little more than half were female (60%).  Asthma diagnosis was 
based on participants self-report of physician diagnosis.  Asthma severity was determined by 
NHBLI guidelines with all asthmatic participants meeting criteria for mild asthma.  No study 
participants endorsed taking corticosteroids.  With the exception of having mild asthma, all 
participants reported being in good physical health.  No participant reported being currently 
treated for a psychiatric disorder.  The presence of depressive symptoms was measured at both 
study time points using the Beck Depression Inventory.  While the scores ranged from 6-15 with 
a mean of 9.3 (SD= 4.4) during the exam and 3.3 (SD= 2.7) during the post-exam period, no 
participant exceeded the established cutoff score of 19 indicating moderate depression.  
However, twenty-five percent of the sample endorsed taking antidepressants.  
In order to determine whether any systematic differences in demographic information 
existed between asthmatic and healthy participants, chi-squared and independent t-tests were 
performed.  Analyses revealed that asthmatic and healthy participants did not differ statistically 
(p>.05) on any of the demographic variables (gender, age, BMI, ethnicity), nor were any 
differences detected among other background variables (antidepressant usage or upper 
respiratory infection scores).   
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Table 1: Means and standard deviations for Demographics and Background Variables 
 Entire Sample 
N= 15 
Asthmatic 
N= 5 
Non-Asthmatic 
N= 10 
Gender (% female) 9/15 (60%) 3/5 (60%) 6/10 (60%) 
Age 27.3 (3.17) 26.2 (2.28) 27.9 (3.51) 
BMI 25.2 (4.62) 24.4 (3.10) 25.6 (5.26) 
Ethnicity (% Caucasian) 13/15 (87%) 4/5 (80%) 9/10 (90%) 
Modified Jackson infection 
score T1 
1.30 (2.19) 1.00 (1.00) 1.45 (2.63) 
Modified Jackson infection 
score T2 
1.47 (2.59) 2.40 (3.29) 1.00 (2.21) 
Antidepressant use T1 4/15 (27%) 1/5 (20%) 3/10 (30%) 
Antidepressant use T2 4/15 (27%) 1/5 (20%) 3/10 (30%) 
 
To identify potential co-variates correlations were computed between demographic 
variables and psychosocial and immune outcomes (Tables 2 and 3). Demographic variables that 
were significantly correlated with psychosocial or immune outcomes at both time points were 
included as covariates in all analyses.  Age and ethnicity were not associated with any 
psychosocial or immune variables at either study time point.  Body mass index (BMI) correlated 
with eosinophil count (r=.64, p=.01) and state anxiety (r=.78, p=.001) during the exam period but 
was not associated with these variables during the low stress period.  Gender was associated with 
eosinophil count during the both the exam (rpb=.70, p=.004) and the post-exam session (rpb=.71, 
p=.003) with males showing a higher level of circulating eosinophils.  As a consequence, gender 
was treated as a covariate in analyses involving numbers of circulating eosinophils.  In addition, 
given the high correlation between BMI and eosinophil count during post-exam and the 
relationship between BMI and inflammatory mediators (Tilg & Moschen, 2006), BMI was also 
treated as a covariate.   
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Table 2: Correlations among immune demographic and background variables 
 Age Ethnicity Gender BMI Psych 
Medication 
Infection 
Score 
Stimulated IFN-gamma 
(pg/ml) 
      
   EXAM -.24 .16 .46 .45 .11 .28 
   POST-EXAM -.09 .11 .34 .17 .25 -.07 
Serum IgE (IU/ml)       
   EXAM -.29 -.02 .21 -.42 -.39 .21 
   POST-EXAM -.31 -.01 .18 -.41 -.32 .46 
Eosinophil Count (x 106 
cells/ml) 
      
   EXAM -.15 .23 .70** .64** .01 .46 
   POST-EXAM -.13 .26 .71** -.01 .12 .49 
**p<.01 
Correlations between background variables, such as the use of antidepressant medication 
and participants’ Modified Jackson criteria infection scores, and psychosocial and immune 
outcomes revealed no association between the use of antidepressant medication and any 
psychological or immune outcome.  In contrast, infection scores during the post-exam period 
were found to be associated with levels of state anxiety (r=.52, p=.045), negative affect (r=.57, 
p=.028) and perceived stress (r=.68, p=.005) during that time point.   Based on these preliminary 
analyses, post-exam infection scores were used as a covariate in analyses involving 
psychological measures. 
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Table 3: Correlations among psychosocial, demographic and background variables 
 Age Ethnicity Gender BMI Psych 
Medication 
Infection 
Score 
Perceived Stress Scale       
   EXAM -.36 -.13 -.06 .26 .05 .38 
   POST-EXAM -.51 .32 .39 .41 .40 .68** 
State Negative Affect 
(PANAS-X) 
      
   EXAM -.10 -.29 -.15 .39 .03 .35 
   POST-EXAM -.41 .22 .38 .23 .11 .57* 
State Anxiety (STAI)       
   EXAM -.12 -.01 .10 .78** .08 .47 
   POST-EXAM -.26 .40 .30 .38 .39 .52* 
Beck Depression  
Inventory 
      
   EXAM -.37 -.58* -.19 .27 -.30 .32 
   POST-EXAM -.50 .36 .46 .43 .11 .68** 
*p<.05, **p<.01 
6.2 HYPOTHESIS 1: ANALYSES AND RESULTS 
It was hypothesized that asthmatic and healthy participants would report higher levels of 
perceived stress, state anxiety and state negative affect during the week prior to the bar exam 
than 1 month following the examination, with no group differences in the magnitude of this 
response.  To examine this hypothesis, 2x2 repeated measure Analysis of Covariance 
(ANCOVA) were conducted, with 2 between group factors (asthmatic vs. non-asthmatic) and 2 
within group factors (examination period vs. post-exam period), to examine differences in levels 
of perceived stress, state anxiety, and negative affect.  
Only participants who completed psychosocial measures at both time points were 
included in these analyses.  As noted earlier, the infection score from the post-exam period was 
significantly correlated with the psychological measures and thus was entered as a covariate in 
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these analyses.   Means and standard deviations for the psychosocial measures are presented in 
Table 4 and Figure 2 depicts changes in perceived stress.  Similar changes were observed for 
state negative affect and state anxiety over time.  Indeed, we observed a main effect of time on 
perceived stress (F(1,13)= 22.98, p=.001, partial eta2 = .657), negative affect (F(1,13)= 14.86, 
p=.003, partial eta2 =.547), and state anxiety (F(1, 13)= 16.38, p= .002, partial eta2 = .577). Both 
asthmatics and non-asthmatics reported significantly more perceived stress, negative affect, and 
state anxiety during the exam period relative to the post-exam period.  As predicted, there was no 
main effect of group or group x time interaction on analysis of any of these parameters, 
indicating that both asthmatic and healthy participants experienced similar levels of distress.   
 
Table 4: Means and standard deviations for psychosocial measures 
  
Asthmatic 
N= 5 
 
Non-Asthmatic 
N= 10 
 
Contrasts (asthmatic vs. 
non-asthmatic) p-value 
 M SD M SD  
Perceived Stress Scale      
   EXAM 16.0 4.4 16.5 5.8 n.s. 
   POST-EXAM 10.2 5.6 8.3 5.8 n.s. 
State Negative Affect 
(PANAS-X) 
     
   EXAM 14.8 6.6 16.1 7.2 n.s. 
   POST-EXAM 6.4 4.7 8.0 4.7  
State Anxiety (STAI)      
   EXAM 44.4 9.3 47.0 11.7 n.s. 
   POST-EXAM 30.8 7.0 33.7 9.2 n.s. 
Beck Depression  
Inventory 
     
   EXAM 9.3 6.4 9.2 3.3 n.s. 
   POST-EXAM 3.2 2.7 3.3 2.8 n.s. 
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Figure 2: Changes in perceived stress from exam to post-exam period after controlling for post-exam   
URI infection score. 
6.3 HYPOTHESIS 2: ANALYSES AND RESULTS 
The second set of hypotheses concerned stress-related changes in immune function, 
specifically cytokine production, among asthmatic and non-asthmatic participants. Here, it was 
hypothesized that there would be baseline differences, with greater stimulated production of the 
Th2 cytokines IL-4 and IL-5. Additionally, it was predicted that asthmatics would show a more 
substantial increase in IL-5, IL-4 and a more substantial decrease in IFN-gamma production in 
response to examination stress when compared with their non-asthmatic counterparts.  
Unfortunately, the assay employed in this study did not reliably stimulate levels of IL-5 and IL-4 
that were detectable using commercial ELISAs and thus IL-4 and IL-5 data could not be 
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included in these analyses.  Levels of IFN-gamma production were quantifiable and results are 
presented below. 
The means and standard deviations for all available immune parameters are presented in 
Table 5.  Stimulated IFN-gamma levels were adjusted for total lymphocyte cell number and were 
natural log transformed to better approximate a normal distribution prior to analysis. As 
expected, unstimulated IFN-gamma levels were undetectable. A group (asthmatic versus non-
asthmatic) x period (exam versus post-exam) repeated measures ANOVA was conducted to 
assess stress-related changes in IFN-gamma production.  These analyses revealed a significant 
interaction (F(1,13)= 14.611, p=.002, partial eta2 squared= .529), which is plotted in Figure 3.  
No main effect of group or time was observed.  Paired and independent t-tests revealed that non-
asthmatics experienced a significant increase in IFN-gamma production from the exam to the 
post-exam period (t(9)= 2.85, p=.019, eta2 = .475).  Change in IFN-gamma production over time 
among asthmatics tended to decrease, but did not achieve statistical significance (t(4)=  -2.38, 
p=.076, eta2 =.585).  However, the large size of the effect of time on IFN-gamma production 
among asthmatics suggests that if there was greater power to detect effects this decrease in IFN-
gamma production may have met statistical significance.  
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Figure 3: Changes in stimulated IFN-gamma from exam to the post-exam period 
 
An independent t-test revealed that during the lower stress post-exam period, asthmatics 
produced significantly less IFN-gamma than healthy participants (t(13)= 2.26, p=.041, eta2 = .28.  
Taken together, these findings suggest there are baseline differences in IFN-gamma production 
between asthmatics and healthy participants.  Moreover, during periods of naturalistic stress 
healthy participants appear to respond with a significant decrease in IFN-gamma production 
while asthmatics show a marginal increase. 
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Table 5: Means and standard deviations for immune outcomes 
  
Asthmatic 
N= 5 
 
Non-asthmatic 
N=10 
 
Contrasts (asthmatic vs. 
non-asthmatic) p-value 
 M SD M SD  
Stimulated IFN-gamma 
(pg/ml)* 
     
   EXAM 0.74 0.31 0.87 0.61 n.s. 
   POST-EXAM 0.52 0.36 1.10 0.57 .041 
Eosinophil count (x 106 
cells/ml) 
     
   EXAM 0.26 0.25 0.28 0.29 n.s. 
   POST-EXAM 0.29 0.18 0.18 0.18 n.s. 
Serum IgE (IU/ml)      
   EXAM 173.6 145.6 62.6 95.6 .031 
   POST-EXAM 187.5 125.8 61.2 90.0 .038 
* adjusted for cell number 
6.4 HYPOTHESIS 3: ANALYSES AND RESULTS 
The third hypothesis examined circulating levels of IgE and numbers of eosinophils. 
Here, it was hypothesized that asthmatics would show greater stress-related increases in 
circulating eosinophils count than non-asthmatics. Moreover, given that both IgE and eosinophil 
number have been associated with asthma severity, it was predicted that asthmatics would show 
greater basal levels of both circulating eosinophils and serum IgE than non-asthmatics. 
Prior to these analyses, serum IgE levels were natural log transformed to better 
approximate a normal distribution.  On analysis of serum IgE, an ANOVA revealed no main 
effect of time or group x time interaction.  As predicted, however, there was a main effect of 
group (F(1, 13)= 5.148, p=.040, partial eta2 = .285) (see Figure 4), indicating that asthmatics had 
higher levels of serum IgE relative to healthy participants across both periods.  These findings 
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are consistent with the literature showing higher levels of serum IgE in asthma, which is largely 
an atopic disease (Novak & Bieber, 2003). 
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Figure 4: Changes in serum IgE from exam to the post-exam period 
 
Absolute eosinophil numbers were also natural log transformed prior to analysis. Here a 
2x2 ANCOVA was employed with gender and BMI as covariates. Results showed no significant 
change in eosinophil number in response to stress (F(1, 11)= .115 p=.702, partial eta2 = .014).  In 
addition, there was no effect of group or group x time interaction.    
In sum, these findings suggest that circulating numbers of eosinophils and levels of IgE 
are not responsive to brief, naturalistic stress.  As expected, asthmatic participants displayed 
higher levels of circulating serum IgE relative to non-asthmatics across both sessions.  In 
contrast, asthmatics and healthy controls showed no difference in circulating eosinophil number.  
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The small size of the sample employed in this study limits our ability to draw firm conclusions 
and as a result findings must be considered preliminary and interpreted with caution.    
6.5 ROLE OF HEALTH BEHAVIORS 
Stress-related changes in health behaviors have been posited as potential pathways 
linking psychological stress to immune function (Kiecolt-glaser & Glaser, 1988). While our 
small sample size limited our statistical power to test the mediating effects of health behaviors, 
exploratory analyses were conducted in the hope that they would help guide future research. 
At both study time points, participants reported on the quality and quantity of their sleep, 
their amount of physical activity and the amount of alcohol consumed over the last week.  In 
addition to recording total alcohol consumption, participants were asked to report the amount of 
alcohol consumed during the week and on the weekends.  Means and standard deviations for 
self-reported health behaviors are provided in Table 6.  Due to missing data, sleep scores were 
only available for 11 participants during the exam period and 13 participants at post-exam.  Data 
was collected from all 15 participants for the remaining health behaviors. To determine whether 
systematic differences in health behaviors existed between asthmatic and non-asthmatic 
participants, independent t-tests were employed; no significant differences were observed.  Next, 
changes in health behaviors across the exam and post-exam periods were examined.  A series of 
2x2 repeated measures ANOVAs revealed no statistically significant group x time interactions, 
or main effects.    
 
 
 37 
Table 6: Means and standard deviations for health behaviors 
  
Asthmatic 
N= 5 
 
Non-Asthmatic 
N= 10 
 
Contrasts (asthmatic vs. 
non-asthmatic) p-value 
 M SD M SD  
PSQI Global Sleep Scorea      
   EXAM 4.8 1.3 6.1 2.0 n.s. 
   POST-EXAM 4.0 1.6 4.2 2.0 n.s. 
Physical Activity (kcal/week)      
   EXAM 1275.5 1355.9 1847.0 1302.6 n.s. 
   POST-EXAM 1929.2 1508.3 2413.8 1893.7 n.s. 
Total alcohol consumption (# 
drinks/week) 
     
   EXAM 5.1 2.7 2.9 2.7 n.s. 
   POST-EXAM 5.3 2.5 3.1 2.6 n.s. 
Alcohol consumption- weekdays 
(# drinks) 
     
   EXAM 1.5 1.5 1.0 1.3 n.s. 
   POST-EXAM 1.5 1.3 0.6 0.8 n.s. 
Alcohol consumption- weekends 
(# drinks) 
     
   EXAM 3.6 1.6 1.9 2.2 n.s. 
   POST-EXAM 3.8 1.3 2.5 2.3 n.s. 
a missing data, exam period (asthmatic n= 4, non-asthmatic n= 7); post-exam (asthmatic n=4, 
non-asthmatic n=9) 
 
In order to explore the association between health behaviors and immune function, 
pearson product-moment correlations were conducted (see Table 7).  The only significant result 
was an association between stimulated IFN-gamma production during the post-exam period and 
alcohol consumption on the weekdays (r=-.66, p=.008) across all participants.  This result 
suggests that during low stress periods individuals who consume more alcohol during the week 
are less able to mount an IFN-gamma response to mitogen stimulation, suggesting a down-
regulation of cellular immune response. It is worth noting that, although failing to achieve 
statistical significance, total alcohol consumption and weekend alcohol consumption were 
moderately correlated with IFN-gamma production during the post-exam period (r=-.47 and r=-
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.27, respectively), providing further support for a possible relationship between alcohol use and 
down-regulation of cellular immune function.   
Table 7: Correlations among immune outcomes and health behaviors 
  
Sleep Score 
 
Physical 
Activity 
 
Total alcohol 
consumption 
 
Alcohol 
consumption- 
weekdays 
 
Alcohol 
consumption- 
weekends 
Stimulated IFN-
gamma (pg/ml) 
     
   EXAM .05 -.19 .01 -.23 .15 
   POST-EXAM -.38 .08 -.47 -.66** -.27 
Serum IgE 
(IU/ml) 
     
   EXAM -.53 .06 .27 .13 .28 
   POST-EXAM .28 .51 .26 .19 .24 
Eosinophil count      
   EXAM .06 -.37 -.04 -.09 .00 
   POST-EXAM .23 .04 .43 .18 .46 
**p<.01 
Given the high correlation between weekday alcohol consumption and post-exam IFN-
gamma production as well as the existing literature suggesting that alcohol can modulate 
immune function, we reanalyzed stress-related changes IFN-gamma production, including post-
exam weekday alcohol consumption as a covariate.  The group x time interaction, though 
marginally reduced, remained significant on analysis of IFN-gamma production (p=.009; change 
in partial eta2 from .53 to .45), suggesting that while alcohol consumption is significantly 
correlated with IFN-gamma production it does not account for the group differences seen during 
the low stress period.  The main effect of time and group remained nonsignificant (p=.456 and 
p=.631). 
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7.0  DISCUSSION 
Growing evidence supports the role of psychological stress in asthma pathogenesis and 
exacerbation (Wright, et al., 1998), with stress-related modulation of Th2 and Th1 cytokine 
production proposed as one potential mediating mechanism.  The aim of the present study was to 
assess the impact of naturalistic stress on Th1:Th2 cytokine production, as well as other asthma-
relevant immune parameters, among mild asthmatics and healthy participants.  For this purpose, 
immune responses to the stress of preparing for the Pennsylvania bar examination were 
evaluated. As expected, this stressor was associated with a significant increase in perceived 
stress, anxiety and negative affect when compared with a follow-up period 1 month later. There 
were no differences among asthmatics and healthy controls in the level of this exam-related 
distress. These emotional changes validate the use of the bar examination as a naturalistic 
stressor.   
7.1 EXAM STRESS AND IFN-GAMMA PRODUCTION 
Immune function was assessed at both study time points. On analysis of stress-related 
changes in stimulated of IFN-gamma production, interesting differences were observed between 
healthy controls and mild asthmatics. Specifically, healthy controls showed a significant stress-
related decrease in IFN-gamma production. In contrast, asthmatics showed a tendency to respond 
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in the opposite direction with an increase in IFN-gamma production from periods of low-to-high 
stress. The stress-related decrease in IFN-gamma that was observed among healthy controls is 
consistent with existing literature demonstrating a down-regulation of Th1 function at times of 
naturalistic stress (Glaser et al., 1986; Marshall et al., 1998; Paik et al., 2000; Segerstrom and 
Miller, 2004), supporting a stress-related down regulation of cellular immune function. Findings 
from the few studies that have examined how stress influences Th-1 cytokine production among 
asthmatics have been less consistent. The present findings do not corroborate earlier observations 
that IFN-gamma production also decreases in response to naturalistic stress among asthmatics 
(Kang and Fox, 2001; Hoglund et al., 2006). However, other studies report no stress-related 
changes in IFN-gamma production among asthmatics (Kang et al., 1997; Liu et al., 2002).  
Furthermore, a recent cross-sectional study showed elevated levels of IFN-gamma production 
among chronically stress asthmatics when compared to their less stressed healthy counterparts 
(Chen et al., 2003).   
Reasons for different findings across studies remain unclear. To date, available findings, 
including those reported here, derive from small studies and it is possible that multiple factors 
contribute to observed inconsistencies in the IFN-gamma responses of asthmatics to stress, 
including differences in the magnitude and chronicity of the stress, in the severity of the asthma, 
in medication use, and in multiple health behaviors that could influence immune competence.  
Further research is warranted to explore these possibilities and determine whether asthmatics 
show reliable differences from healthy controls in their IFN-gamma responses to naturalistic 
stress. 
In addition to stress effects, the current findings reveal lower baseline levels of IFN-
gamma production among asthmatics than healthy controls. This finding is consistent with 
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previous reports (Rodriguez et al., 1998) and with studies showing that higher ratios of Th2:Th1 
cytokine production are associated with asthma (Bettiol et al., 2000). Indeed, a growing literature 
suggests that asthma is characterized by higher than normal Th2 cytokine production (Liu, 
2000). In light of evidence that Th2 cytokines inhibit the production of Th1 cytokines, it is likely 
that the immune cells of asthmatics are primed by the inhibitory properties of the Th2 cytokines 
to produce lower levels of Th1 cytokines, possibly accounting for the lower levels of IFN-
gamma observed in the current study.    
IFN-gamma plays an integral role in cell-mediated immunity which is, in part, 
responsible for protecting the body from viral infections. Prior findings have shown that 
asthmatics are more susceptible to URI than non-asthmatics (Busse, 1990), suggesting that 
diminished resistance to viral infection may accompany this disease. As a major trigger of 
asthma episodes, increased susceptibility to URIs may play a role in the pathophysiology of this 
disease. Thus, dampened IFN-gamma production following mitogen challenge may be a 
biomarker of a downregulated, or impaired, cellular immune pathway which results in increased 
risk of asthma. Future studies would benefit from the inclusion of other Th1 cytokines, such as 
IL-2, that also play an important role in host resistance and from an examination of how Th1 
cytokine production may contribute asthma pathogenesis.   
7.2 EXAM STRESS, IgE, AND EOSINOPHIL COUNT 
In addition to an examination of T-helper derived cytokines, the current study examined 
how stress impacted two other parameters of relevance to allergic pathology, circulating numbers 
of eosinophils and serum levels of IgE. In regard to eosinophil number, the current findings did 
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not corroborate an earlier observation that the percentage of eosinophils in peripheral circulation 
increases in response to naturalistic stress among asthmatics (Liu et al., 2002). Indeed, no stress-
related changes in eosinophil number were observed for mild asthmatics or controls.  The present 
findings did provide some support for existing findings that asthmatics have higher circulating 
numbers of eosinophils than non-asthmatics (Lewis et al., 2001; Ulrik, 1998), with a tendency 
for asthmatics to show higher eosinophil numbers across both measurement periods than 
controls. It is possible that the failure of this effect to achieve significance denotes a lack of 
robust association between asthma and eosinophil number. A second and more likely explanation 
is that the present study lacks the statistical power necessary to detect effects. Previous research 
reporting group differences had a larger subject numbers and hence more power than the present 
investigation.  
A final possible explanation for our failure to find more convincing group differences in 
eosinophil counts is the inclusion of only mild asthmatics. Recent research suggests that the 
elevation in circulating numbers of eosinophils observed among asthmatics is secondary to an 
increase in circulating levels of IL-5, which occurs during the late phase of an asthma attack (Shi 
et al., 1998).  The mild asthmatics recruited for the current study rarely experience asthma 
attacks and do not require asthma control medications.  Previous research  demonstrating 
differences in eosinophil counts between asthmatics and controls has included individuals with 
more moderate asthma who experience more frequent exacerbation of their disease (Krishna et 
al.,  2001).   Further attempts to determine whether eosinophil counts vary by asthma severity 
and differentiate asthmatics from healthy controls is warranted if the interpretation of these 
results is to be elucidated.  
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On analysis of serum IgE levels, our findings revealed an expected group difference, with 
asthmatics demonstrating higher levels across both measurement periods than healthy controls.  
This is consistent with existing literature (Novak & Bieber, 2003; Krishna et al., 2001) and 
supports the atopic nature of asthma. There were no stress-related changes in serum IgE levels 
among asthmatics or controls. 
7.3 EXAM STRESS AND CHANGES IN HEALTH BEHAVIORS 
Stress-related changes in health behaviors are considered a possible pathway linking 
psychological stress to increased disease susceptibility and exacerbation (Kiecolt-Glaser & 
Glaser, 1988).  A growing body of evidence suggests that stress is associated with decreased 
physical activity (Ng & Jeffery, 2003; Heslop et al., 2001), decreased sleep quality (Hall et al., 
2000), and increased alcohol consumption (Heslop et al., 2001; Steptoe, Wardle, Pollard, 
Canaan, and Davies, 1996). In contrast, the current study does not reveal a consistent relationship 
between examination stress and any of these health behaviors.   Given the existing evidence 
supporting these relationships, it seems unlikely that this failure to find effects reflects the lack of 
a robust association. As before, it is more likely that this reflects the lack of statistical power to 
detect effects.   Indeed, an examination of the observed relationships demonstrates that most of 
these relationships are in the expected directions, with effect sizes in the range to achieve 
significance with more subjects. The exception to this is alcohol consumption, which decreased 
slightly during the exam period.  It is possible the absence of stress-related changes in health 
behaviors reflect the role of moderating variables, such as social support. In this regard, 
perceived availability of social resources has been demonstrated to buffer the appraisal of a 
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situation as stressful and impact health behavioral choices (Cohen, 2004).    Consistent with the 
current findings, Steptoe and colleagues (1996) found no main effect of examination stress on 
alcohol consumption among 115 students. However, they did find a significant social support x 
time interaction with individuals high in social support reporting a decrease in alcohol 
consumption during examinations and those with low support endorsing an increase in alcohol 
consumption, supporting a moderating role of social support in stress-related alcohol use.  Future 
work assessing social support as well as other potential moderators, e.g. self-esteem, perceived 
coping ability, and social network size, may aid in the interpretation of relationships between 
stress and health behaviors.  
7.4 IFN-GAMMA PRODUCTION AND ALCOHOL CONSUMPTION 
Interestingly, weekday alcohol consumption during the low stress period was inversely 
correlated with stimulated IFN-gamma production across both asthma and control groups.  These 
findings corroborate a growing literature demonstrating an association between alcohol use and 
the decreased ability of Th1 cells to secrete IFN-gamma (Shellito, 1998; Waltenbaugh, Vasquez 
and Peterson, 1998).  Indeed, decreased IFN-gamma production has been observed in response to 
both chronic and acute alcohol administration (Szabo, 1999).  
To date, findings with respect to the impact of alcohol on asthma exacerbation have been 
mixed.  While some beneficial effects of alcohol on asthma have been reported, such as the 
capacity for alcohol to reduce airway sensitivity (Cuddy, 2001), much of literature focuses on 
alcohol-related downregulation of immune function (Szabo, 1999). There were no group 
differences in alcohol consumption during the low stress period; thus, it is unlikely that alcohol 
 45 
use account for differences across asthmatics and controls in IFN-gamma production. This was 
confirmed by multivariate analyses showing that alcohol use does not account for much of the 
between group variance in IFN-gamma production.  Nevertheless associations between alcohol 
use and a down-regulation of cellular immune pathways warrant further investigation and may 
be relevant to susceptibility to viral infections.  
7.5 BIOLOGICAL PATHWAYS 
Activation of the HPA axis and associated release of cortisol is one potential mechanism 
of stress-related changes in IFN-gamma production among healthy participants.  Indeed, 
evidence supports stress-related activation of the HPA axis, as measured by increased levels of 
cortisol in peripheral circulation (Wolkowitz et al., 2001).  Cortisol plays an important role in the 
modulation of immune function.  Of relevance to the current findings, cortisol can act on T-cells 
to potentiate Th2 cytokine production and downregulate Th1 cytokines responses. For example, 
Argawal and Marshall (1998) treated lymphocytes taken from healthy individuals with varying 
concentrations of the synthetic corticosteroid, dexamethasone and observed significant decreases 
in IFN-gamma production and a concomitant increase in the production of Th2 cytokines, 
including IL-4 and IL-10. Thus, it is possible that stress-related cortisol release accounted for the 
decrease in IFN-gamma production observed among the control group in the current study. 
Interestingly, however, the asthmatic subjects tended to show the opposite effect, with stress 
related increases in IFN-gamma production. Reasons for this are less clear. One possible 
explanation is a decrease in the sensitivity of immune cells to cortisol that has been reported 
among asthmatics (Leung, 1995), which could result in an increase in IFN-gamma production. It 
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remains to be determined whether this decline in glucocorticoid sensitivity is an individual 
difference associated with asthma pathogenesis or is an adaptation to the chronic use of 
corticosteroids in the treatment of asthma or to prolonged elevation of cortisol resulting from 
chronic stress. It is unlikely that chronic steroid use accounts for any glucocorticoid resistance in 
the current sample of mild asthmatics; however further research examining the possible role of 
glucocorticoid resistance is warranted.      
Activation of the sympathetic and parasympathetic branches of the ANS are other 
mechanisms by which naturalistic stress may influence IFN-gamma production among asthmatic 
and healthy participants.  Indeed, stress-induced activation of the sympathetic nervous system 
has been shown to modulate lymphocyte distribution (Bachen et al., 1995; Kin & Sanders, 2006) 
and to promote Th2 cytokine production. In vitro findings demonstrate that immune cells 
exposed to the sympathetic neurotransmitter epinephrine show a significant increase in Th2 
production and a concomitant decrease in IFN-gamma (Agarwal & Marshall, 2000).  
Parasympathetic activation, often associated with bronchoconstriction, also has 
immunomodulatory effects.  For instance, experimental studies show that eosinophils interact 
with cholinergic nerve fibers to induce the release of acetylcholine, a chemical mediator of 
bronchoconstriction (Sawatzky et al., 2003).  In addition, emerging evidence suggests that vagal 
activity can directly influence cytokine production.  While not yet applied to asthma-relevant 
immune parameters vagal activation has been shown to downregulate the inflammatory response 
(Tracey, 2002).  Future studies examining role of vagal activity on asthma relevant cytokine 
production may shed further light on the multiple pathways between the central nervous and 
immune systems.     
 47 
7.6 LIMITATIONS 
There are a number of limitations of the present study.  First, interpretation of results is 
hindered by the small sample size. Thus, findings should be considered as preliminary and 
interpreted with caution.  Although other studies demonstrating relationships between stress and 
asthma-relevant immune parameters have also employed small samples sizes, e.g. 13 asthmatics 
in the study by Kang and Fox (2001), the current study only included 5 individuals with mild 
asthma. Nevertheless, the current findings provide some initial evidence that mild asthmatics 
differ from matched healthy controls in their ability to produce IFN-gamma, an important Th1 
cytokine that is involved in cellular immune function. Further research to determine whether this 
is a robust difference is warranted, especially given the possibility that a dysregulation of Th1 
pathways may render individuals more susceptibly to viral infections, which are a common 
trigger of asthma exacerbation. 
Another limitation of the current study was a failure of the stimulation assay to 
successfully activate T-helper cells and upregulate the expression of Th2 cytokines.  Despite 
pilot testing designed to ensure that the concentration of PHA (10 ug/ml) employed in the current 
assay was adequate to produce a quantifiable Th2 response, and prior research demonstrating 
that 10 ug/ml of PHA reliably stimulates T cell activation, we were unable to detect reliable 
levels of Th2 cytokines when the stimulated samples stored from the current study were analyzed 
by ELISA. Reasons for this technical problem remain unclear. One possible explanation is that 
the potency of the PHA was lower than originally anticipated. Findings from other assays 
conducted in the laboratory around the same time and using the same batch of PHA suggest that 
this may have been the case. Indeed, when employed in another study to stimulated lymphocyte 
proliferation, this batch of PHA resulted in lower than expected cell counts.   IFN-gamma is 
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typically produced at higher concentrations than IL-4 or IL-5.  As a consequence, it appears that 
IFN-gamma levels fell in the detectable range while the Th2 cytokines did not. In light of these 
results, further preliminary testing is indicated before the current study is replicated to determine 
whether stress influences the production of Th-2 cytokines among asthmatics   
Finally, this study was limited by the exclusive recruitment of mild asthmatics.  Previous 
studies utilizing more severe asthmatics have found more significant stress-related immune 
effects (Chen et al, 2003).  Indeed, authors of previous studies examining stress-related immune 
changes among only mild asthmatics have suggested that utilizing individuals with mild disease 
makes it difficult to discern asthmatics from healthy controls (Kang et al., 1997).  That said, 
however, more severe asthmatics often rely on medications known to affect the immune and 
endocrine system thus confounding studies aimed at examining the stress-immune link.   
7.7 FUTURE DIRECTIONS 
The present findings contribute to a growing literature demonstrating immune changes in 
response to naturalistic stress.  Moreover, intriguing basal differences in IFN-gamma production 
provide initial evidence for possible diminished host resistance among asthmatics when 
compared with matched health controls.  Taken together, these findings suggest that future 
studies examining the relationship between psychological stress, susceptibility to viral infection 
and asthma exacerbation should be conducted.  Further examination of whether stress influences 
the production of Th2 cytokines and other immune parameters known to be related to the 
exacerbation of asthma is also indicated.  Emerging research indicates that stress impacts a 
variety of biological processes relevant to asthma.  For instance, oxidative stress, shown to be 
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exacerbated by psychological stress (Forlenza & Miller, 2006), has been postulated to enhance 
inflammation among asthmatics (Wright et al., 2005).  Additionally, stress-induced break down 
in negative feedback loops, e.g. glucocorticoid resistance, may contribute to prolonged 
inflammatory processes in asthma (Wright et al., 2005). 
Stress-related changes in health behaviors remain a possible pathway linking stress to 
asthma exacerbation, either directly or via behaviorally-related modulation of immune function. 
In this regard, future investigations would benefit from the exploration of the role of a range of 
health behaviors.  Given the inverse relationship between IFN-gamma production and alcohol 
consumption reported in the current study, future work measuring alcohol consumption in a more 
rigorous fashion is indicated. For instance, the use of daily diaries to more reliably track alcohol 
use would be beneficial.  Additionally, manipulation of alcohol consumption or the recruitment 
of asthmatics that chronically consume alcohol may help to elucidate the role of alcohol in the 
exacerbation of asthma. 
In addition to determining the underlying mechanisms linking stress and asthma 
exacerbation, it is a hope that knowledge about the impact of stress or the course of asthma will 
translate from the benchtop to the bedside in the form of clinical interventions.  To date, asthma 
interventions have focused primarily on pulmonary function with mixed success (Lehrer et al., 
2002). Others have examined the benefit of teaching relaxation as a form of stress management. 
Here, the results have been mixed. Among healthy individuals, relaxation training has been 
associated with both a shift towards (Carlson, Speca, Patel and Goodey, 2003) and away from 
(Jones, 2001) Th2 cytokine production.  Future studies measuring both pulmonary function and 
asthma relevant cytokine production in response to psychosocial interventions is warranted. 
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8.0  CONCLUSION 
In conclusion, this study provides initial evidence of stress-related changes in asthma 
relevant immune parameters among healthy and mild asthmatic participants.  Indeed, consistent 
with previous research, findings suggest a stress-related decrease in IFN-gamma production 
among healthy participants while asthmatics responded with a marginal increase.  In addition, 
and consistent with a tendency for asthmatics to have poorer host resistance, basal differences in 
IFN-gamma were observed with asthmatics producing lower levels when compared to healthy 
individuals.  No other stress-related differences in asthma relevant immune parameters were 
observed; however, as expected, asthmatics did show higher levels of circulating IgE across both 
study time points.  Finally, exploratory analyses of health behaviors revealed an intriguing 
relationship between alcohol consumption and IFN-gamma production that warrants further 
investigation.  Future studies employing larger sample sizes are needed to better interpret these 
findings.  Moreover, an accurate assessment of Th2 cytokine production, as well as other 
biological processes emerging in the asthma literature, e.g. glucocorticoid sensitivity and 
oxidative stress, will help to elucidate the various pathways linking stress and asthma and inform 
the development of appropriate clinical interventions.  Together with an understanding of the 
underlying pathophysiology, the role of health behaviors and the impact of naturalistic stress, it 
is a hope that, over time, interventions will be designed to make asthma a more manageable 
disease.    
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